2 hours agoPolitics
38LENS
8 SourcesIdaho, United States
thebalanced.newsU.S. Reclassifies Certain Medical Marijuana Products, Eases Federal Restrictions
The U.S. Department of Justice has reclassified FDA-approved and state-licensed medical marijuana products from Schedule I to Schedule III, recognizing their lower potential for abuse and accepted medical use. This policy shift, directed by President Trump, does not legalize marijuana federally but aims to ease research restrictions, reduce tax burdens, and support the cannabis industry. A formal hearing is scheduled for June 2026 to consider broader marijuana rescheduling under federal law.
Political Bias
10%88%2%
Sentiment
68%
AI Analysis
Political bias across 8 sources
● Left 10%● Center 88%● Right 2%
The article group presents a range of perspectives focusing on the federal government's policy change under the Trump administration. Sources highlight the administration's efforts to align drug classification with medical research and industry needs, while noting that full legalization is not achieved. Coverage includes government statements, industry reactions, and contextualizes the shift within ongoing state-level legalization debates, reflecting a primarily policy-focused framing without partisan bias.
Sentiment — Positive (68/100)
Overall sentiment across the articles is cautiously positive, emphasizing the potential benefits for medical research, patient access, and the cannabis industry. The tone acknowledges the limitations of the policy change, such as the absence of full federal legalization, while highlighting optimism about reduced regulatory barriers and upcoming hearings. The coverage balances hopeful industry and patient perspectives with factual reporting on legal constraints.
How 8 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| economictimes | US to loosen marijuana rules in major shift for 47 billion industry | Center | Neutral |
| indiatoday | US to relax marijuana curbs, reclassifies some products as less dangerous | Center | Neutral |
| mint | US reclassifies some Marijuana products as less dangerous; hearing set for June 2026 Today News | Center | Neutral |
| theprint | US to loosen marijuana rules in major shift for 47 billion industry | Center | Positive |
| hindustantimes | US eases cannabis for medical use: Access, research, and regulation explained | Center | Positive |
| economictimes | Has Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock Market | Center | Positive |
| news18 | Weed Gets Relief In America: Why US Just Took Its Biggest Cannabis Step Yet | Center | Neutral |
| theprint | US reclassifies certain marijuana products as a less-dangerous drug | Center | Positive |
Coverage timeline
theprint broke this story on 23 Apr, 01:07 pm. Other outlets followed.
- 1theprint23 Apr, 01:07 pmUS reclassifies certain marijuana products as a less-dangerous drug
- 2news1823 Apr, 02:48 pmWeed Gets Relief In America: Why US Just Took Its Biggest Cannabis Step Yet
- 3economictimes23 Apr, 03:17 pmHas Donald Trump administration made Marijuana legal for medical or recreational use in U.S.? Shares of cannabis firms jump big in U.S. Stock Market
- 4hindustantimes23 Apr, 03:54 pmUS eases cannabis for medical use: Access, research, and regulation explained
- 5theprint23 Apr, 04:04 pmUS to loosen marijuana rules in major shift for 47 billion industry
- 6mint23 Apr, 04:24 pmUS reclassifies some Marijuana products as less dangerous; hearing set for June 2026 Today News
- 7indiatoday24 Apr, 01:31 amUS to relax marijuana curbs, reclassifies some products as less dangerous
- 8economictimes24 Apr, 03:43 amUS to loosen marijuana rules in major shift for 47 billion industry
Lens Score breakdown
38/100
Public interest0/100
Coverage gap90%
Story is receiving appropriate media attention relative to public interest.
Who's involved
Institutions and figures named across source coverage.
Government
Justice DepartmentDepartment of JusticeOffice of the Acting Attorney GeneralFDAU.S. Drug Enforcement AdministrationFood and Drug AdministrationUS Federal Government
Corporate
Cronos GroupAurora CannabisVeranoTilray BrandsTrulieve CannabisCanopy Growth
Story context
- Category
- Politics
- Location
- Idaho, United States
- Sources analysed
- 8
- Last analysed
- 24 Apr 2026
- Key entities
- Cannabis (drug)Controlled Substances ActUnited States Department of JusticeMedical cannabisFederal government of the United StatesDonald TrumpUnited States Attorney GeneralHeroinExecutive order (United States)Recreational drug useFood and Drug AdministrationTilray
Related Coverage
Select a news story to see related coverage from other media outlets.